Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-25-000021

President & CEO gave up 22,217 shares (to pay taxes)

  • President & CEO acquired 223,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hirsch Andrew · President & CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-14 Grant or award : show line 1 in the form +223,500 445,362 D
2025-02-14 Shares withheld for taxes : show line 2 in the form −12,847 $3.18 $40,853 432,515 D
2025-02-15 Shares withheld for taxes : show line 3 in the form −9,370 $3.18 $29,797 423,145 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-14 Grant or award : show line 4 in the form Stock Option (Right to Buy) +335,300 335,300 D
Loading xslF345X05/wk-form4_1739915729.xml…